Carl D’Ruiz is a leading voice in sunscreen photoprotection, OTC drug modernization, and risk‑based safety science, with more than three decades of experience advancing consumer health and regulatory innovation. He is widely recognized for shaping U.S. sunscreen policy, leading pivotal FDA OTC submissions, and championing science‑driven regulatory pathways that enable safer, more effective UV filters and next‑generation skincare technologies.

Currently with dsm‑firmenich, and formerly Chair of the Personal Care Products Council (PCPC) Sunscreen Consortium, Carl has played a central role in strengthening sun‑safety advocacy across Congress, federal agencies, and major medical societies. His work has accelerated the adoption of non‑animal test methods, modern toxicology frameworks, and sustainability standards that elevate patient safety and consumer protection.

A Yale University graduate with a Master of Public Health, Carl is a full member of the Society of Toxicology, a member of the Society of Cosmetic Chemists Scientific Affairs Committee and serves on the Board of the Photodermatology Society. He is also an adjunct member of the American Academy of Dermatology and an active contributor to multiple scientific and professional organizations, continuing to shape the future of photoprotection and evidence‑based skincare innovation.